TherVacB: Advance Curative Strategy for Chronic Hepatitis B
more
Stories about Pharmakologie
Fraunhofer-Institut für Produktionstechnologie IPT
Transforming personalized medicine with AI-driven CAR-T manufacturing: Automated CAR-T cell production platform is ready for production
morePress Release : STADA brings in Henshaw from Biogen to head Specialty as Kim leads Western Europe
One documentmorePress Release: STADA’s continued, resilient growth leads to record earnings in Q1
One documentmore- 3
Key technology for bioprocesses
more Centor Launches Smart Pill Organizer to Support Medication Adherence
more
SHL Medical opens new US$220 million manufacturing facility in the US to serve growing autoinjector market
moreSGLT2 HYPE: New EU-funded Project Aims to Transform Hypertension Treatment
more- 3
Press Release STADA’s growth journey continues in 2024 - Significant increase in sales and profits - Growing ahead of the market
One documentmore LTS Lohmann Therapie-Systeme AG
LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships
moreSCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissues
moreGrünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer
more
RHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers
moreGerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
moreStrides Pharma International AG
Strides Pharma Consolidates European Business-to-Business Operations in Switzerland
moreInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies
more- 2
SHL Medical announces plans to establish SHL Advantec
more Event Announcement: VIROFIGHT Hybrid Symposium
One documentmore
RHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
more- 2
Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.
One documentmore - 2
Record financing rounds at the Munich biotech hub
One documentmore Press release: STADA continues strong growth journey in the first half of 2024
One documentmore- 2
Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patients
more - 10
Gerresheimer: New pictures available
more
canSERV invites applications for "Revolutionising Cancer Patient Care"
One documentmore- 3
canSERV invites applications for "Revolutionising Cancer Patient Care"
One documentmore - 2
Gerresheimer partners with RxCap to offer connected adherence solutions
more Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment
morePress release: STADA continues with double-digit sales and profit growth in 2023
One documentmoreResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
more
123Next